John Rapoport
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
John Rapoport has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Stanley Lemeshow
From the Department of Economics, Mount Holyoke College, South Hadley, Massachusetts
2 shared publicationsDan Teres
1 shared publicationDaniel Md Teres
From the Department of Economics, Mount Holyoke College, South Hadley, Massachusetts
1 shared publicationDaniel Teres
1 shared publicationJay Steingrub
1 shared publicationPhil Jacobs
1 shared publication
Latest Publications
- 1 December 2004
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 32 (12) , 2564
Affordable Health Care
- 1 December 2004
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 32 (12) , 2564
Affordable Health Care
- 1 March 2003
- Published by Wolters Kluwer Health in Medical Care
- Vol. 41 (3) , 386-397
Length of Stay Data as a Guide to Hospital Economic Performance for ICU Patients
Context. Length of stay data are increasingly used to monitor ICU economic performance. How such material is presented greatly affects its utility. Objective. To develop a weighted length of stay index and to estimate expected length of stay. To assess alternative ways to summarize weighted length of stay to evaluate ICU economic performance. Design. Retrospective database study. Subjects. Data for 751 ICU patients in 1998 at two hospitals used to develop weighted length of stay index. Data on 42,237 patients from 72 ICUs used as the basis of economic performance evaluation. Main Outcome Measures. Difference between actual and expected weighted length of stay, where expected weighted length of stay is based on patient clinical characteristics. Results. Length of stay statistically explains approximately 85 to 90% of interpatient variation in hospital costs. The first ICU day is approximately four times as expensive, and other ICU days approximately 2.5 times as expensive, as non-ICU hospital days. In a regression model for weighted length of stay, patient clinical characteristics explain 26% of variation. ICU economic performance can be measured by excess weighted length of stay of a “typical” patient or by occurrence of long excess weighted lengths of stay. Although different summary measures of performance are highly correlated, choice of measure affects relative ranking of some ICUs’ performance Conclusion. Providers of statistical data on ICU economic performance should adjust length of stay for patient characteristics and provide multiple summary measures of the statistical distribution, including measures that address both the typical patient and outliers.
- 1 March 2003
- Published by Wolters Kluwer Health in Medical Care
- Vol. 41 (3) , 386-397
Length of Stay Data as a Guide to Hospital Economic Performance for ICU Patients
Context. Length of stay data are increasingly used to monitor ICU economic performance. How such material is presented greatly affects its utility. Objective. To develop a weighted length of stay index and to estimate expected length of stay. To assess alternative ways to summarize weighted length of stay to evaluate ICU economic performance. Design. Retrospective database study. Subjects. Data for 751 ICU patients in 1998 at two hospitals used to develop weighted length of stay index. Data on 42,237 patients from 72 ICUs used as the basis of economic performance evaluation. Main Outcome Measures. Difference between actual and expected weighted length of stay, where expected weighted length of stay is based on patient clinical characteristics. Results. Length of stay statistically explains approximately 85 to 90% of interpatient variation in hospital costs. The first ICU day is approximately four times as expensive, and other ICU days approximately 2.5 times as expensive, as non-ICU hospital days. In a regression model for weighted length of stay, patient clinical characteristics explain 26% of variation. ICU economic performance can be measured by excess weighted length of stay of a “typical” patient or by occurrence of long excess weighted lengths of stay. Although different summary measures of performance are highly correlated, choice of measure affects relative ranking of some ICUs’ performance Conclusion. Providers of statistical data on ICU economic performance should adjust length of stay for patient characteristics and provide multiple summary measures of the statistical distribution, including measures that address both the typical patient and outliers.
- Open Access
- 17 May 2000
- Published by American Medical Association (AMA) in JAMA
- Vol. 283 (19) , 2559-2567
Patient Characteristics and ICU Organizational Factors That Influence Frequency of Pulmonary Artery Catheterization
Use of a particular technology in practice can have major clinical and economic implications. This article examines associations between clinical and demographic characteristics, organizational aspects of practice setting, type of reimbursement, and physician decisions to monitor intensive care unit (ICU) patients with the pulmonary artery catheter (PAC). Introduced in the early 1970s, PAC monitoring in the ICU increased quickly, despite the fact that its effectiveness has never been demonstrated convincingly in a sufficiently powered randomized controlled trial.1 Several studies have examined the effectiveness of the PAC in specific patient groups, with variable findings.2-4 A recent study based on a large sample of ICU patients showed that patients with a PAC had higher-than-predicted mortality, as well as higher costs and length of stay compared with patients who were not monitored with a catheter.5 The question of what is appropriate use of this technology has been considered in several consensus conferences.6,7
- 17 May 2000
- Published by American Medical Association (AMA) in JAMA
- Vol. 283 (19) , 2559-2567
Open AccessPatient Characteristics and ICU Organizational Factors That Influence Frequency of Pulmonary Artery Catheterization
Use of a particular technology in practice can have major clinical and economic implications. This article examines associations between clinical and demographic characteristics, organizational aspects of practice setting, type of reimbursement, and physician decisions to monitor intensive care unit (ICU) patients with the pulmonary artery catheter (PAC). Introduced in the early 1970s, PAC monitoring in the ICU increased quickly, despite the fact that its effectiveness has never been demonstrated convincingly in a sufficiently powered randomized controlled trial.1 Several studies have examined the effectiveness of the PAC in specific patient groups, with variable findings.2-4 A recent study based on a large sample of ICU patients showed that patients with a PAC had higher-than-predicted mortality, as well as higher costs and length of stay compared with patients who were not monitored with a catheter.5 The question of what is appropriate use of this technology has been considered in several consensus conferences.6,7